The Signaling Network Resulting in Ventilator-induced Diaphragm Dysfunction.

Area of Science:

• Biomedical Engineering
• Physiology
• Pathology

Background:

• Mechanical ventilation (MV) is crucial for respiratory support but can cause ventilator-induced diaphragm dysfunction (VIDD).
• VIDD leads to diaphragm weakness, complicating ventilator weaning and increasing mortality.
• Preventing VIDD is vital for improving patient outcomes and reducing death rates.

Purpose of the Study:

• To summarize the current understanding of the molecular pathogenesis of VIDD.
• To identify key molecular pathways and signaling molecules involved in VIDD.
• To highlight potential drug targets for preventing or treating VIDD.

Main Methods:

• Review of existing literature on molecular mechanisms of VIDD in humans and animals.
• Analysis of cellular processes including protein degradation, energy metabolism, and mitochondrial function.
• Examination of signaling pathways (Smad3, STAT3, FoxO) and their role in mitochondrial oxidative stress.

Main Results:

• VIDD involves diaphragm muscle fiber atrophy due to protein degradation (ubiquitin-proteasome system, autophagy, apoptosis, calpain).
• Mitochondrial dysfunction, oxidative stress, and altered energy metabolism (impaired oxidative phosphorylation, increased glycolysis) are central to VIDD.
• Signaling molecules like Smad3, STAT3, and FoxO modulate mitochondrial function, with MV rapidly activating Smad3 and STAT3 to increase oxidative stress.

Conclusions:

• Mitochondrial oxidative stress is a central factor in VIDD pathogenesis.
• Signaling pathways involving Smad3, STAT3, FoxO, angiotensin II, and calcium regulation contribute to VIDD.
• Identified molecular pathways offer promising drug targets for clinical trials to prevent VIDD.